Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...
The best aero helmets offer a chance to add aerodynamics to something you already need, don’t leave free watts on the table Upgrading to one of the best aero helmets is an easy way to go faster ...
F-22 Raptor stealth fighter jet pilots are getting a new high-tech helmet that will make them even deadlier in the skies. Starting with the Hawaii Air National Guard, F-22 Raptor pilots will now ...
Unlike a single-piece full-face helmet, a flip-front has a separate chin-bar that lifts up, exposing the face while the helmet is still on. Not only does this allow people to see your face for ID ...
Love riding in the classic sense? You should look the part. And while the riders of yore made do with minimal protection (or none), modern materials and design mean you don’t have to choose ...
Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals, has positioned it as an important, non-opioid option for pain ...
And while motorcycle helmets have long been all about protection, Sena has just made its new range of helmets smart. Sena has been at the forefront of motorcycle connectivity for several decades.
Ski helmets weren’t a thing when I graduated from ski school 30 years ago. But these days? My helmet is the first thing I pack whether I’m skiing at my home ski resort in Montana or traveling ...
Vertex's total revenues for Q4 2024 were $178.5 million, marking a 15.2% increase year-over-year. How much did Vertex invest in research and development for 2025? Vertex plans to invest ...
The end of the Vertex-Verve collaboration comes as investors are reevaluating once sky-high expectations for the gene editing industry as commercial realities set in. Shares of Verve and top companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results